SETDB1 and cancer: Evidence in support of this occurring in cancer includes loss of SET Domain Bifurcated Histone Lysine Methyltransferase 1 (SETDB1), an epigenetic regulator of TE expression, resulting in TE upregulation in murine models of lung cancer and melanoma.